Continuous Glucose Monitoring Systems (CGMS) Market Expected to Reach $4,921 Million by 2024, Says Allied Market Research

Continuous Glucose Monitoring Systems (CGMS) Market Expected to Reach $4,921 Million by 2024, Says Allied Market Research

PR Newswire

PORTLAND, Oregon and PUNE, India, July 9, 2018

PORTLAND, Oregon and PUNE, India, July 9, 2018 /PRNewswire/ --

According to a new report published by Allied Market Research, titled, "Continuous Glucose Monitoring Systems (CGMS) Market by Components, Demographics, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the market was valued at $894 million in 2016, and is projected to reach $4,921 million by 2024, registering a CAGR of 22.9% from 2018 to 2024.

     (Logo: )

The continuous glucose monitoring systems (CGMS) market has emerged as a promising diabetes management tool for monitoring all types of diabetic patients. Replacement/repeat sales of components such as sensors drive the growth of the CGMS market. Continuous glucose monitoring systems are mainly used by patients suffering from hypo and hyperglycemic conditions. Rise in incidences of diabetes worldwide, benefits of CGMS devices over POC glucometers, increase in awareness in developing and underdeveloped economies, and technological advancements with focus on developing CGMS devices majorly drive the CGM market. However, lack of adequate reimbursement for devices is the key barrier to the adoption of the devices.

Request Sample Report at:

By component, sensors generated the maximum revenue, accounting for more than two-thirds share of the global continuous glucose monitoring systems market in 2016. By demographics, adult population was the highest revenue generating segment in 2016 while child population was the segment with the highest CAGR during the forecast period

Key Findings of the Continuous Glucose Monitoring Systems (CGMS) Market: 

For Purchase Enquiry:

Geographical analysis shows, North America and Europe are the most lucrative market segments in the global CGMs market. High purchasing power that renders increased affordability for CGMS devices are the key factors responsible for the growth of this market in Europe and North America. Asia-Pacific market is expected to grow at a highest CAGR of 29.7% over the analysis period and thus constitutes potential market opportunity for the new market players. Moreover, factors such as rise in the number of patients with diabetes, growth in the purchasing power of the patients and awareness can positively impact the growth of the market in this region.

The major companies profiled in the report are Abbott Laboratories, Dexcom, Inc., A. Menarini Diagnostics, Echo Therapeutics, Inc., Insulet Corporation, GlySens Incorporated, Johnson & Johnson, Medtronic plc, Senseonics Holdings, Inc., and F. Hoffmann-La Roche Ltd.

Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at:

Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas. 

Similar Reports: 

Holter ECG Monitoring Market - Global Opportunity Analysis and Industry Forecast, 2017-2023

Blood Pressure Monitoring Devices Market - Global Opportunity Analysis and Industry Forecast, 2014-2022

About Us 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975


Voltar noticias em Inglês